ICU MedicalNASDAQ: ICUI

SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical's presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 20, 2024.

SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical's presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, March 4, 2024.

ICU Medical (ICUI) came out with quarterly earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.60 per share a year ago.

SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call.

ICU Medical, Inc. has faced disappointment and poor performance due to previous acquisitions and lower-quality business activities. The company's recent acquisition of Smiths Medical Business did not meet sales expectations, leading to a shortfall in earnings. ICU Medical's stock has declined significantly, and its leverage ratios are high, causing concerns amidst sales declines of the business.

ICU Medical, Inc. (NASDAQ:ICUI ) Q3 2023 Results Conference Call November 6, 2023 4:30 PM ET Company Participants John Mills - Managing Partner at ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Larry Solow - CJS Securities Jayson Bedford - Raymond James Operator Good afternoon. And welcome to the ICU Medical Inc. Third Quarter 2023 Earnings Conference Call [Operator Instructions].

The Plum Duo infusion pump represents the latest addition to ICU Medical's (ICUI) advanced lineup of infusion devices.

ICU Medical's deal with Smiths Medical is underperforming, following a previous troubled deal with Hospira Infusion Systems. Shares have fallen by 50% over the past two years, as the company's outlook is uncertain. The business is facing quality issues and higher interest costs, and its leverage is still high.

ICU Medical (ICUI) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.37 per share a year ago.